ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.61 CNY | +0.73% |
|
-0.93% | -31.75% |
| 05-29 | Starry Pharma Gets China Nod for MRI Contrast Agent Injectable | MT |
| 05-28 | Zhejiang Starry Pharmaceutical Co.,Ltd. announced that it has received CNY 934.979955 million in funding | CI |
Evolution of the average Target Price on Zhejiang Starry Pharmaceutical Co.,Ltd.
Price target over the last 5 years
History of analyst recommendation changes
096866cba509c6efb981165c803d1.vAxZ78AauCl0CnvRXOFmnu27zd3t09wgCK9Q4SMDxQs.6Fsxo6Qp13YlZE6IcY5S16fQqeu3v7oWQewXoFBctF3QZSiltlH0YTxaMg~084a0dad571d1138159a389dc1619350
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.61
CNY
Average target price
17.54
CNY
Spread / Average Target
+82.52%
High Price Target
17.54
CNY
Spread / Highest target
+82.52%
Low Price Target
17.54
CNY
Spread / Lowest Target
+82.52%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603520 Stock
- Consensus Zhejiang Starry Pharmaceutical Co.,Ltd.
